Compare XPEL & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XPEL | BLFS |
|---|---|---|
| Founded | 1999 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | N/A | 1989 |
| Metric | XPEL | BLFS |
|---|---|---|
| Price | $54.78 | $22.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 204.9K | ★ 357.6K |
| Earning Date | 02-25-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.69 | N/A |
| Revenue | ★ $461,460,000.00 | $100,144,000.00 |
| Revenue This Year | $16.20 | $18.45 |
| Revenue Next Year | $11.28 | $16.27 |
| P/E Ratio | $31.90 | ★ N/A |
| Revenue Growth | 10.29 | ★ 87.53 |
| 52 Week Low | $24.25 | $19.10 |
| 52 Week High | $55.91 | $29.62 |
| Indicator | XPEL | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 54.60 | 40.63 |
| Support Level | $50.35 | $21.45 |
| Resistance Level | $55.91 | $22.99 |
| Average True Range (ATR) | 1.84 | 1.09 |
| MACD | -0.03 | -0.07 |
| Stochastic Oscillator | 60.25 | 21.19 |
XPEL Inc is a supplier of protective films, coatings, and related services to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from the sale of automotive products and related services while the remainder of its revenue is derived from non-automotive products including architectural window film and marine and flat surface protection films. The majority of revenue is derived from the United States.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.